Histology of metastatic colorectal cancer in a lymph node

Background A primary colorectal cancer (CRC) tumor can contain heterogeneous cancer cells. As clones of cells with different properties metastasize to lymph nodes (LNs), they could show different morphologies. Cancer histologies in LNs of CRC remains to be described. Methods Our study enrolled 318 consecutive patients with CRC who underwent primary tumor resection with lymph node dissection between January 2011 and June 2016. 119 (37.4%) patients who had metastatic LNs (mLNs) were finally included in this study. Cancer histologies in LNs were classified and compared with pathologically diagnosed differentiation in the primary lesion. The association between histologies in lymph node metastasis (LNM) and prognosis in patients with CRC was investigated. Results The histologies of the cancer cells in the mLNs were classified into four types: tubular, cribriform, poorly differentiated, and mucinous. Same degree of pathologically diagnosed differentiation in the primary tumor produced various histological types in LNM. In Kaplan–Meier analysis, prognosis was worse in CRC patients with moderately differentiated adenocarcinoma who had at least some mLN also showing cribriform carcinoma than for those whose mLNs all showed tubular carcinoma. Conclusions Histology in LNM from CRC might indicate the heterogeneity and malignant phenotype of the disease.

[1]  S. Schoenberg,et al.  Identification of CT Imaging Phenotypes of Colorectal Liver Metastases from Radiomics Signatures—Towards Assessment of Interlesional Tumor Heterogeneity , 2022, Cancers.

[2]  T. Sugai,et al.  Cribriform-type adenocarcinoma of the colorectum: comprehensive molecular analyses of a distinctive histologic subtype of colorectal cancer , 2022, Carcinogenesis.

[3]  M. Westerhoff,et al.  Cribriform colon cancer: a morphological growth pattern associated with extramural venous invasion, nodal metastases and microsatellite stability , 2021, Journal of Clinical Pathology.

[4]  Y. Nakatani,et al.  Cribriform carcinoma in the lymph nodes is associated with distant metastasis, recurrence, and survival among patients with node-positive colorectal cancer. , 2021, The British journal of surgery.

[5]  C. Díaz del Arco,et al.  Colorectal cribriform comedo-type adenocarcinoma: a distinct subtype with poor prognosis? , 2019 .

[6]  H. Fujii,et al.  Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer , 2018, AntiCancer Research.

[7]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[8]  E. Fearon,et al.  Lymph Node Metastases in Colon Cancer Are Polyclonal , 2017, Clinical Cancer Research.

[9]  Mari Mino-Kenudson,et al.  Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer. , 2016, Cancer discovery.

[10]  L. Lino-Silva,et al.  Colonic Cribriform Carcinoma, a Morphologic Pattern Associated With Low Survival , 2015, International journal of surgical pathology.

[11]  H. Yamaue,et al.  CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil , 2015, Cancer Chemotherapy and Pharmacology.

[12]  R. Halaoui,et al.  Rewiring cell polarity signaling in cancer , 2014, Oncogene.

[13]  D. Aust.  [WHO classification 2010 for the lower gastrointestinal tract: what is new?]. , 2011, Der Pathologe.

[14]  H. Yamaue,et al.  Hollow spheroids beyond the invasive margin indicate the malignant potential of colorectal cancer , 2011, BMJ Open.

[15]  D. Coradini,et al.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment , 2011, Acta Pharmacologica Sinica.

[16]  F. D. De Braud,et al.  Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Gottardi,et al.  Cadherins and cancer: how does cadherin dysfunction promote tumor progression? , 2008, Oncogene.

[18]  J. Shively,et al.  Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation , 2007, Oncogene.

[19]  Inke Näthke,et al.  Cell polarity in development and cancer , 2007, Nature Cell Biology.

[20]  J. Shively,et al.  Mutation Analysis of the Short Cytoplasmic Domain of the Cell-Cell Adhesion Molecule CEACAM1 Identifies Residues That Orchestrate Actin Binding and Lumen Formation* , 2007, Journal of Biological Chemistry.

[21]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[22]  Pingfang Liu,et al.  CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Y. Sun,et al.  Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. , 1999, Journal of cell science.

[24]  H. Wieand,et al.  Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.